SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-087859
Filing Date
2024-08-09
Accepted
2024-08-09 17:00:47
Documents
13
Period of Report
2024-08-09
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2421322d1_8k.htm   iXBRL 8-K 28774
  Complete submission text file 0001104659-24-087859.txt   201952

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA clrb-20240809.xsd EX-101.SCH 3018
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE clrb-20240809_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clrb-20240809_pre.xml EX-101.PRE 22361
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2421322d1_8k_htm.xml XML 3568
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Filer) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36598 | Film No.: 241193815
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)